BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 23780926)

  • 1. Correspondence to C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Kumar A; Sagar S; Kumar K
    Neurosurg Rev; 2024 Apr; 47(1):184. PubMed ID: 38652354
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.
    Bao C; Zhou D; Zhu L; Qian W; Ye X
    Transl Cancer Res; 2020 Apr; 9(4):2378-2389. PubMed ID: 35117598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High C-Reactive Protein to Albumin Ratio Predicts Inferior Clinical Outcomes in Extranodal Natural Killer T-Cell Lymphoma.
    Di QS; Xu T; Song Y; Zuo ZG; Cao FJ; Yu XJ; Tang JY; Zhang W; Li C; Wan GX; Cai XJ
    Dose Response; 2020; 18(2):1559325820917824. PubMed ID: 32284703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.
    Zhao Q; Fan S; Chang Y; Liu X; Li W; Ma Q; Li Y; Wang Y; Zhang L; Zhang M
    Cancer Manag Res; 2019; 11():3555-3564. PubMed ID: 31118779
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma.
    Zeng LS; Huang WT; Qiu T; Shan L; Guo L; Ying JM; Lyu N; Feng XL
    Chronic Dis Transl Med; 2017 Dec; 3(4):252-259. PubMed ID: 29354808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.
    Li Y; Yang C; Mao L; Wang J; Li C; Qian W
    Medicine (Baltimore); 2017 Sep; 96(39):e8091. PubMed ID: 28953629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
    Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
    Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma.
    Bi XW; Wang L; Zhang WW; Yan SM; Sun P; Xia Y; Li ZM; Jiang WQ
    PeerJ; 2016; 4():e1742. PubMed ID: 26966671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.
    Wang YQ; Yang Y; Zhuo HY; Zou LQ; Jiang Y; Jiang M
    Med Oncol; 2015 Feb; 32(2):435. PubMed ID: 25572807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
    Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
    Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies.
    Kim TM; Heo DS
    Cancer Sci; 2009 Dec; 100(12):2242-8. PubMed ID: 19758393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
    Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
    Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.